These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 1030071
1. [Use of the cell-separator in the treatment of factor-VIII-inhibitor hemophilia]. Piller G, Druml W, Höcker P, Niessner H, Rainer H, Lechner K. Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1654-9. PubMed ID: 1030071 [No Abstract] [Full Text] [Related]
3. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)]. Okubo S, Ikuma T, Hamaguchi Y, Yasunaga K. Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716 [No Abstract] [Full Text] [Related]
4. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C, Patharathienskul D, Suvatte V. Southeast Asian J Trop Med Public Health; 1993 May; 24 Suppl 1():106-12. PubMed ID: 7886549 [Abstract] [Full Text] [Related]
7. Factor VIII inhibitor treatment. Economics of inhibitor treatment in Canada. Rivard GE, Vick S. Semin Hematol; 1994 Apr; 31(2 Suppl 4):41-3. PubMed ID: 7939774 [No Abstract] [Full Text] [Related]
8. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor]. Klukowska A, Zieleniewska B. Acta Haematol Pol; 1994 Apr; 25(4):349-54. PubMed ID: 7847036 [Abstract] [Full Text] [Related]
9. The economics of factor VIII inhibitor treatment. Lipton RA. Semin Hematol; 1994 Apr; 31(2 Suppl 4):37-8. PubMed ID: 7939772 [No Abstract] [Full Text] [Related]
11. [Factor VIII inhibitor-caused hemophilia]. Peto I, Bánhegyi D, Nemesánszky E, Köves A, Sas G. Orv Hetil; 1977 Sep 04; 118(36):2145-9. PubMed ID: 917507 [No Abstract] [Full Text] [Related]
14. [Suppression of factor VIII inhibitor in children with hemophilia A]. Zenz W, Muntean W. Padiatr Padol; 1987 Sep 04; 22(4):345-52. PubMed ID: 3125510 [Abstract] [Full Text] [Related]
16. [Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII]. Weippert M, Anders O, Schmidt M, Roewer J. Beitr Infusionsther; 1990 Sep 04; 26():174-8. PubMed ID: 1703823 [Abstract] [Full Text] [Related]
17. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin. Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Thromb Haemost; 1995 Aug 04; 74(2):619-21. PubMed ID: 8584995 [Abstract] [Full Text] [Related]
18. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols. Mariani G, Scheibel E, Nogao T, Kasper CK, Ewing NP, Mauser-Bunschoten E, Ghirardini A, Bellocco R, Brackman HH. Semin Hematol; 1994 Apr 04; 31(2 Suppl 4):62-4. PubMed ID: 7939781 [No Abstract] [Full Text] [Related]
19. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates. de Biasi R, Rocino A, Papa ML, Salerno E, Mastrullo L, De Blasi D. Thromb Haemost; 1994 May 04; 71(5):544-7. PubMed ID: 8091377 [Abstract] [Full Text] [Related]
20. The use of intravenous immunoglobulins in the treatment of factor VIII inhibitors. Sultan Y, Kazatchkine MD, Algiman M, Dietrich G, Nydegger U. Semin Hematol; 1994 Apr 04; 31(2 Suppl 4):65-6. PubMed ID: 7939782 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]